Listen Now

Topics Covered

• Overview and Definition of Biosimilars
• The Difference Between Biosimilars and Generic Drugs
• How Biosimilars Work and Their Use
• Examples of Biosimilars
• Implications in Managing the Costs of Cancer Treatment
• Clinical Trials: How Biosimilar Research Contributes to Treatment Options
• The Benefits of Biosimilars
• Current Use in the Care of People Living with Cancer
• Key Questions to Ask Your Health Care Team About Biosimilars
• Current and Future Perspectives
• Questions for Our Panel of Experts

Our Panel of Experts

Richard J. Gralla, MD, FACP

Professor of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center

Jeffrey Crawford, MD

George Barth Geller Professor for Research in Cancer, Department of Medicine, Duke University School of Medicine, Co-Director, Solid Tumor Therapeutics Program, Duke Cancer Institute

Lisa M. Thompson, PharmD, BCOP

Pharmacy Program Coordinator, PGY2 Oncology Residency Program Director, Banner MD Anderson Cancer Center

Caroline Edlund, MSW

Online Support Group Program Director, CancerCare

Brochure

You can download the brochure for this workshop(80.3 KB)

Workshop Date

This workshop was originally recorded on February 1, 2017.